JOURNAL OF EXPERIMENTAL MEDICINE
Scope & Guideline
Elevating Experimental Medicine to New Heights
Introduction
Aims and Scopes
- Immunology and Immune Response:
The journal publishes research exploring the mechanisms of immune responses, including the roles of various immune cells, cytokines, and signaling pathways in health and disease. This includes studies on T cells, B cells, innate lymphoid cells, and their interactions with pathogens. - Cancer Immunotherapy:
A significant focus is on the development and evaluation of cancer immunotherapies, including checkpoint inhibitors, CAR-T cell therapies, and vaccine strategies. Research often investigates the mechanisms of tumor immune evasion and the potential for enhancing anti-tumor immunity. - Autoimmunity and Inflammation:
The journal features studies examining the underlying mechanisms of autoimmune diseases and chronic inflammatory conditions, including the roles of autoantibodies and immune cell dysregulation. - Infectious Diseases:
Research related to the immune response to infectious agents, including viral, bacterial, and parasitic infections, is a core area. The journal emphasizes understanding host-pathogen interactions and the development of therapeutic strategies. - Cellular and Molecular Mechanisms:
Papers often delve into the cellular and molecular basis of disease, including studies on signaling pathways, gene regulation, and cellular metabolism that influence immune function and disease outcomes. - Translational Medicine:
The journal aims to bridge basic research with clinical applications, encouraging studies that translate findings from the laboratory into potential therapeutic interventions for various diseases.
Trending and Emerging
- Single-Cell Analysis Techniques:
There is a notable increase in studies utilizing single-cell RNA sequencing and other single-cell technologies to dissect cellular heterogeneity within the immune system and tumors. This trend underscores the importance of understanding individual cell behaviors in complex biological systems. - Personalized and Precision Medicine:
Research focusing on personalized approaches to immunotherapy, including the identification of biomarkers for treatment response and tailoring therapies to individual patient profiles, is rapidly emerging as a significant theme. - Microbiome and Immune Interactions:
Studies exploring the relationship between the microbiome and immune system health are increasingly featured. This includes research on how gut microbiota influence immune responses and disease outcomes. - Inflammation and Metabolism:
The intersection of metabolic processes and immune function is gaining attention, with research investigating how metabolic pathways influence immune cell behavior and chronic inflammation. - Therapeutic Target Identification:
There is a growing trend towards identifying and validating novel therapeutic targets within the immune system and cancer biology, reflecting the journal's commitment to translational research.
Declining or Waning
- Basic Virology:
Research focused solely on the basic virology of pathogens, without a strong emphasis on immune responses or therapeutic implications, has seen a decline. The journal increasingly favors studies that link virology with immunological outcomes. - In vitro Studies Without Clinical Relevance:
There appears to be a waning interest in in vitro studies that do not translate to in vivo or clinical contexts. The journal favors studies that provide insights into real-world applications or mechanisms in living systems. - Non-immune Cell Focused Research:
Research that primarily focuses on non-immune cells in isolation, without considering their interactions with the immune system, has become less prominent. The journal emphasizes the importance of immune cell interactions.
Similar Journals
FASEB BioAdvances
Unlocking the Secrets of Life SciencesFASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.
EUROPEAN JOURNAL OF IMMUNOLOGY
Driving Discoveries in the World of ImmunologyWelcome to the European Journal of Immunology, a premier peer-reviewed journal dedicated to advancing the field of immunology and allergy research. Established in 1971 and published by Wiley, this esteemed journal has been consistently ranked in the top quartile (Q1) across its categories, highlighting its significant impact within the scientific community. With an impressive Scopus ranking, the journal occupies the 64th position in Immunology and Allergy and the 74th in the broader sector of Immunology and Microbiology, demonstrating its vital role in driving innovation and knowledge in immunological studies. The European Journal of Immunology publishes high-quality original research, comprehensive reviews, and insightful commentary, making it an indispensable resource for researchers, healthcare professionals, and students dedicated to understanding the complexities of the immune system. Although not an open-access journal, it offers various subscription options to ensure that institutions and individuals can access pivotal research that shapes the future of immunology.
Immune Network
Bridging Disciplines for a Healthier TomorrowImmune Network is a prestigious journal dedicated to disseminating high-quality research in the field of immunology, infectious diseases, and allergy, under the esteemed KOREA ASSOCIATION OF IMMUNOLOGISTS. Founded in 2016, this journal has quickly ascended to a top-tier publication, achieving Q1 rankings in 2023 in multiple relevant categories, including Immunology, Allergy, and Infectious Diseases. With a strong emphasis on innovation and interdisciplinary research, Immune Network appeals to a diverse audience of researchers, professionals, and students keen on advancing the understanding of immune responses and disease mechanisms. However, it is crucial to note that the journal operates under a subscription model without open-access provisions. Its impact factor further solidifies its reputation, reflecting the significant influence of the articles published. Located in South Korea, the journal serves as a global platform for sharing revolutionary insights and fostering collaborations within the immunology community.
IMMUNOBIOLOGY
Advancing the frontiers of immunology and hematology.IMMUNOBIOLOGY is a prestigious academic journal published by Elsevier GmbH that significantly contributes to the fields of hematology and immunology. With its ISSN 0171-2985 and E-ISSN 1878-3279, this journal has been disseminating impactful research since 1979, positioning itself at the forefront of immunological and hematological advances. The journal holds a commendable ranking of Q2 in Hematology and Q3 in both Immunology and Immunology and Allergy, indicating its relevance and influence within the scientific community, as reflected by its Scopus rankings. Although IMMUNOBIOLOGY operates under a subscription model, it remains dedicated to expanding knowledge across disciplines, fostering innovative research, and facilitating connections among researchers, professionals, and students. Situated in Munich, Germany, this journal is continually evolving and aims to remain an essential resource for the latest discoveries and insights in the realms of immunity and blood disorders, ultimately enhancing our understanding of complex biological systems.
FASEB JOURNAL
Connecting Researchers to Transformative DiscoveriesFASEB JOURNAL, published by Wiley, stands as a leading interdisciplinary platform in the realm of biological sciences, prominently featured in the United States. With an impressive 2023 impact factor placing it in the Q1 category across various fields including Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine (miscellaneous), the journal is recognized for its substantial contribution to advancing knowledge and innovation. It serves as a vital resource for researchers, professionals, and students alike, providing high-quality, peer-reviewed articles that explore the molecular and cellular mechanisms underlying health and disease. The FASEB JOURNAL not only emphasizes accessible scientific communication but also fosters collaboration within these dynamic fields, making it an essential publication for anyone engaged in cutting-edge life sciences research. To explore more about the journal's offerings and access its vast repository of scholarly articles, visit their official page.
INFLAMMATION RESEARCH
Illuminating the pathways of inflammation research.INFLAMMATION RESEARCH, published by SPRINGER BASEL AG, serves as a pivotal journal in the fields of Immunology and Pharmacology, with notable rankings of Q2 in Immunology and Q1 in Pharmacology as of 2023. With an ISSN of 1023-3830 and an E-ISSN of 1420-908X, this esteemed journal, located in Basel, Switzerland, has been at the forefront of advancing our understanding of inflammatory processes since its inception in 1995. Covering research trends and breakthroughs until 2024, it significantly contributes to both the theoretical frameworks and practical applications within its discipline, boasting a strong Scopus ranking of #40/313 in Pharmacology and #56/236 in Immunology, placing it in the top percentiles for its field. Although it does not offer Open Access options, the journal remains an invaluable resource for researchers, professionals, and students committed to unraveling the complexities of inflammation and its implications in health and disease.
JOURNAL OF IMMUNOLOGY
Driving Discoveries in Immune HealthWelcome to the JOURNAL OF IMMUNOLOGY, a prestigious publication associated with the American Association of Immunologists and dedicated to advancing the field of immunology. With a rich history dating back to 1945, this journal is renowned for its high-impact research, evident in its notable 2023 Q1 rankings in both Immunology and Allergy, as well as its strong positions in Scopus rankings—Rank #68 in Immunology and Allergy and Rank #79 in Immunology and Microbiology. Although it operates on a subscription basis, its commitment to publishing cutting-edge studies ensures that it remains a vital resource for scientists, healthcare professionals, and students alike. As the journal continues to pave the way for innovative research and breakthroughs in immunological science, it facilitates a platform for dialogue and discovery among researchers and practitioners across the globe.
IMMUNOLOGY AND CELL BIOLOGY
Advancing the Frontiers of Immunology and Cell BiologyIMUNOLOGY AND CELL BIOLOGY, published by Wiley, serves as a prominent platform for disseminating cutting-edge research in the fields of immunology and cell biology. With an ISSN of 0818-9641 and an E-ISSN of 1440-1711, this journal has established itself since its inception in 1987, demonstrating a commitment to advancing knowledge in its disciplines through high-quality articles. Renowned for its rigorous peer-review process, it holds a Q2 quartile ranking in both immunology and cell biology categories as of 2023, showing its competitive stature in these fields. IMUNOLOGY AND CELL BIOLOGY is indexed among the elite journals worldwide, with impressive Scopus rankings, including a rank of #75/233 in Immunology and Allergy. The journal’s comprehensive scope ensures that it caters to an audience of researchers, professionals, and students who are dedicated to exploring the intricate mechanisms of immune responses and cellular interactions. Although it does not operate under an open access model, its subscription-based content remains invaluable for those seeking to broaden their understanding of immunology and cell biology. By providing a forum for significant scientific dialogue, IMUNOLOGY AND CELL BIOLOGY continues to shape the future of research in these vital areas.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Pioneering Discoveries in Immunology and AllergyClinical and Experimental Immunology, published by Oxford University Press, is a premier journal that has been a cornerstone in the field of immunology since its inception in 1966. With an ISSN of 0009-9104 and an E-ISSN of 1365-2249, this journal holds a significant position in academic research, currently ranking in the Q2 category for both Immunology and Allergy (2023). Its impactful contributions are reflected in its Scopus rankings, where it stands at Rank #63 out of 233 in Immunology and Allergy, placing it in the 73rd percentile, and Rank #73 out of 236 in Immunology and Microbiology. Researchers, healthcare professionals, and students will find this journal an invaluable resource for cutting-edge studies, reviews, and clinical advancements in the ever-evolving domain of immunology. While the publication does not offer open-access options, it remains a pivotal platform for disseminating knowledge that impacts both clinical practice and experimental research.
Cellular & Molecular Immunology
Advancing Immunological FrontiersCellular & Molecular Immunology is a prestigious peer-reviewed journal published by the CHIN SOCIETY IMMUNOLOGY. As a leading journal in the fields of immunology and infectious diseases, it proudly holds a Q1 designation across multiple categories, including Immunology, Allergy, and Medicine (Miscellaneous), reflecting its commitment to excellence and impactful research. With an ISSN of 1672-7681 and an E-ISSN of 2042-0226, the journal has been essential reading since its inception in 2004, continuously gathering insights from cutting-edge studies. It ranks impressively within Scopus, with positions in the 7th, 8th, and 9th percentile in relevant categories, establishing it as a cornerstone for researchers, clinicians, and students alike. The journal offers an extensive range of original research articles, reviews, and clinical studies, ensuring that readers stay at the forefront of immunological discovery. Whether you are interested in basic immunology, infectious diseases, or evolving therapies, Cellular & Molecular Immunology serves as an invaluable resource for advancing your knowledge and engagement in this dynamic field.